1-5 of 5
Gautam Sethi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

Repurposing FDA Approved Drugs as FXR Agonists: A Structure Based in silico Pharmacological Study

Sandra Jose, Sreevidya S. Devi, Anjana Sajeev, Sosmitha Girisa, Mohammed Alqahtani, Mohamed Abbas, Abdulrahman Alshammari, Gautam Sethi, Ajaikumar Kunnumakkara
Journal: Bioscience Reports
Biosci Rep (2022) BSR20212791.
DOI: https://doi.org/10.1042/BSR20212791
Published: 29 March 2022
View article
PDF
Articles

Engineering anti-cancer nanovaccine based on antigen cross-presentation

Vaishnavi U. Warrier, Amina I. Makandar, Manoj Garg, Gautam Sethi, Ravi Kant, Jayanta K. Pal, Eiji Yuba, Rajesh Kumar Gupta
Journal: Bioscience Reports
Biosci Rep (2019) 39 (10): BSR20193220.
DOI: https://doi.org/10.1042/BSR20193220
Published: 18 October 2019
View article
PDF
Articles

Role of RNF20 in cancer development and progression – a comprehensive review

Gautam Sethi, Muthu K. Shanmugam, Frank Arfuso, Alan Prem Kumar
Journal: Bioscience Reports
Biosci Rep (2018) 38 (4): BSR20171287.
DOI: https://doi.org/10.1042/BSR20171287
Published: 13 July 2018
View article
PDF
Articles

SREBP-1c as a molecular bridge between lipogenesis and cell cycle progression of clear cell renal carcinoma

Gautam Sethi, Muthu K. Shanmugam, Alan Prem Kumar
Journal: Bioscience Reports
Biosci Rep (2017) 37 (6): BSR20171270.
DOI: https://doi.org/10.1042/BSR20171270
Published: 15 December 2017
View article
PDF
Articles

Multifaceted link between cancer and inflammation

Gautam Sethi, Muthu K. Shanmugam, Lalitha Ramachandran, Alan Prem Kumar, Vinay Tergaonkar
Journal: Bioscience Reports
Biosci Rep (2012) 32 (1): 1–15.
DOI: https://doi.org/10.1042/BSR20100136
Published: 26 September 2011
View article
PDF